How Human Tumor Tissues Support Regulatory Approvals in Oncology Trials

Regulatory approvals in oncology demand robust, patient-relevant evidence. This article explores how human tumor tissues, including human tissue samples, human tissue specimens, and frozen human tissue, play a vital role in supporting safety, efficacy, and biomarker validation in cancer drug trials. Learn how pharma companies, biotech firms, and clinical research organizations can leverage partnerships with a biospecimen company for research to accelerate approvals and bring life-saving therapies to patients faster.